137 related articles for article (PubMed ID: 9692458)
1. Heparin-coated bypass circuits: effects on inflammatory response in pediatric cardiac operations.
Schreurs HH; Wijers MJ; Gu YJ; van Oeveren W; van Domburg RT; de Boer JH; Bogers AJ
Ann Thorac Surg; 1998 Jul; 66(1):166-71. PubMed ID: 9692458
[TBL] [Abstract][Full Text] [Related]
2. Biocompatibility of heparin-coated extracorporeal bypass circuits: a randomized, masked clinical trial.
Muehrcke DD; McCarthy PM; Kottke-Marchant K; Harasaki H; Pierre-Yared J; Borsh JA; Ogella DA; Cosgrove DM
J Thorac Cardiovasc Surg; 1996 Aug; 112(2):472-83. PubMed ID: 8751516
[TBL] [Abstract][Full Text] [Related]
3. Centrifugal pump and heparin coating improves cardiopulmonary bypass biocompatibility.
Moen O; Fosse E; Dregelid E; Brockmeier V; Andersson C; Høgåsen K; Venge P; Mollnes TE; Kierulf P
Ann Thorac Surg; 1996 Oct; 62(4):1134-40. PubMed ID: 8823102
[TBL] [Abstract][Full Text] [Related]
4. Heparin-coated cardiopulmonary bypass circuit: clinical effects in pediatric cardiac surgery.
Miyaji K; Hannan RL; Ojito J; Jacobs JP; White JA; Burke RP
J Card Surg; 2000; 15(3):194-8. PubMed ID: 11414605
[TBL] [Abstract][Full Text] [Related]
5. Biocompatibility of silicone-coated oxygenator in cardiopulmonary bypass.
Shimamoto A; Kanemitsu S; Fujinaga K; Takao M; Onoda K; Shimono T; Tanaka K; Shimpo H; Yada I
Ann Thorac Surg; 2000 Jan; 69(1):115-20. PubMed ID: 10654498
[TBL] [Abstract][Full Text] [Related]
6. Limitation of thrombin generation, platelet activation, and inflammation by elimination of cardiotomy suction in patients undergoing coronary artery bypass grafting treated with heparin-bonded circuits.
Aldea GS; Soltow LO; Chandler WL; Triggs CM; Vocelka CR; Crockett GI; Shin YT; Curtis WE; Verrier ED
J Thorac Cardiovasc Surg; 2002 Apr; 123(4):742-55. PubMed ID: 11986603
[TBL] [Abstract][Full Text] [Related]
7. Comparison of two heparin-coated extracorporeal circuits with reduced systemic anticoagulation in routine coronary artery bypass operations.
Ovrum E; Tangen G; Oystese R; Ringdal MA; Istad R
J Thorac Cardiovasc Surg; 2001 Feb; 121(2):324-30. PubMed ID: 11174738
[TBL] [Abstract][Full Text] [Related]
8. Influence of Duraflo II heparin-treated extracorporeal circuits on the systemic inflammatory response in patients having coronary bypass.
Weerwind PW; Maessen JG; van Tits LJ; Stad RK; Fransen EJ; de Jong DS; Penn OC
J Thorac Cardiovasc Surg; 1995 Dec; 110(6):1633-41. PubMed ID: 8523873
[TBL] [Abstract][Full Text] [Related]
9. No benefit of reduced heparinization in thoracic aortic operation with heparin-coated bypass circuits.
Olsson C; Siegbahn A; Haldén E; Nilsson B; Venge P; Thelin S
Ann Thorac Surg; 2000 Mar; 69(3):743-9. PubMed ID: 10750754
[TBL] [Abstract][Full Text] [Related]
10. Heparin-coated circuits reduce the formation of TNF alpha during cardiopulmonary bypass.
Yamada H; Kudoh I; Hirose Y; Toyoshima M; Abe H; Kurahashi K
Acta Anaesthesiol Scand; 1996 Mar; 40(3):311-7. PubMed ID: 8721461
[TBL] [Abstract][Full Text] [Related]
11. Complement and granulocyte activation in two different types of heparinized extracorporeal circuits.
Ovrum E; Mollnes TE; Fosse E; Holen EA; Tangen G; Abdelnoor M; Ringdal MA; Oystese R; Venge P
J Thorac Cardiovasc Surg; 1995 Dec; 110(6):1623-32. PubMed ID: 8523872
[TBL] [Abstract][Full Text] [Related]
12. High and low heparin dose with heparin-coated cardiopulmonary bypass: activation of complement and granulocytes.
Ovrum E; Mollnes TE; Fosse E; Holen EA; Tangen G; Ringdal MA; Videm V
Ann Thorac Surg; 1995 Dec; 60(6):1755-61. PubMed ID: 8787476
[TBL] [Abstract][Full Text] [Related]
13. Heparin-coated cardiopulmonary bypass circuits reduce circulating complement factors and interleukin-6 in paediatric heart surgery.
Olsson C; Siegbahn A; Henze A; Nilsson B; Venge P; Joachimsson PO; Thelin S
Scand Cardiovasc J; 2000; 34(1):33-40. PubMed ID: 10816058
[TBL] [Abstract][Full Text] [Related]
14. Cardiopulmonary bypass circuit treated with surface-modifying additives: a clinical evaluation of blood compatibility.
Gu YJ; Boonstra PW; Rijnsburger AA; Haan J; van Oeveren W
Ann Thorac Surg; 1998 May; 65(5):1342-7. PubMed ID: 9594864
[TBL] [Abstract][Full Text] [Related]
15. Heparin-coated circuits reduce complement activation and inflammatory response to cardiopulmonary bypass.
Tamim M; Demircin M; Guvener M; Peker O; Yilmaz M
Panminerva Med; 1999 Sep; 41(3):193-8. PubMed ID: 10568115
[TBL] [Abstract][Full Text] [Related]
16. Influence of two different perfusion systems on inflammatory response in pediatric heart surgery.
Jensen E; Andréasson S; Bengtsson A; Berggren H; Ekroth R; Lindholm L; Ouchterlony J
Ann Thorac Surg; 2003 Mar; 75(3):919-25. PubMed ID: 12645717
[TBL] [Abstract][Full Text] [Related]
17. Deleterious effects of cardiopulmonary bypass on early graft function after single lung allotransplantation: evaluation of a heparin-coated bypass circuit.
Francalancia NA; Aeba R; Yousem SA; Griffith BP; Marrone GC
J Heart Lung Transplant; 1994; 13(3):498-507. PubMed ID: 8061027
[TBL] [Abstract][Full Text] [Related]
18. Disparity in blood activation by two different heparin-coated cardiopulmonary bypass systems.
Moen O; Fosse E; Brockmeier V; Andersson C; Mollnes TE; Høgåsen K; Venge P
Ann Thorac Surg; 1995 Nov; 60(5):1317-23. PubMed ID: 8526620
[TBL] [Abstract][Full Text] [Related]
19. Release of proinflammatory cytokines during pediatric cardiopulmonary bypass: heparin-bonded versus nonbonded oxygenators.
Ashraf S; Tian Y; Cowan D; Entress A; Martin PG; Watterson KG
Ann Thorac Surg; 1997 Dec; 64(6):1790-4. PubMed ID: 9436574
[TBL] [Abstract][Full Text] [Related]
20. Comparison of three oxygenator-coated and one total-circuit-coated extracorporeal devices.
Baksaas ST; Videm V; Pedersen T; Karlsen H; Mollnes TE; Brosstad F; Svennevig JL
Perfusion; 1999 Mar; 14(2):119-27. PubMed ID: 10338323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
